1. Home
  2. Live Updates
  3. Kalbe genexine biologics

Live Breaking News & Updates on Kalbe Genexine Biologics

Stay updated with breaking news from Kalbe genexine biologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reviewing I-Mab (NASDAQ:IMAB) and Cerevel Therapeutics (NASDAQ:CERE)

I-Mab (NASDAQ:IMAB – Get Free Report) and Cerevel Therapeutics (NASDAQ:CERE – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 22.6% of I-Mab shares are […] ....

United Kingdom , United States , Kalbe Genexine Biologics , Abbvie Ireland Unlimited Company , Sinopharm Group Co , Jumpcan Pharmaceutical Group , Cerevel Therapeutics Holdings Inc , Get Free Report , Cerevel Therapeutics , Giveni Mab , Cerevel Therapeutic , Genexine Biologics , Sinopharm Group , Therapeutics Holdings , I Mab Daily , I Mab , Nasdaq Imab , Stock Comparison , Stock Analysis ,

Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)

SEOUL, South Korea (BUSINESS WIRE) Oct 23, 2023 ....

Soult Ukpyolsi , South Korea , Kalbe Farma , Kalbe Genexine Biologics Kgbio , Roche Mircera , Jongsoo Lee , Sungjune Hong , Kalbe Genexine Biologics , Genexine Inc , Consumer Health Division , Prescription Pharmaceuticals Division , Indonesian Ministry Of Food , Indonesia Stock Exchange , Nutritional Division , Distribution Logistics Division , Genexine Biologics , Indonesian Ministry , Drug Safety , Korean Biopharma , President Director , Sie Djohan , Southeast Asian , Pediatric Growth Hormone Deficiency , Western Europe , Business Wire ,

Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

/PRNewswire/ Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab. ....

United States , United Kingdom , Jing Huang , Fosun Pharma , Wenjie Zhang , Kalbe Genexine Biologics Kgbio , Jason Zhu , Cancer Hospital Chinese Academy Of Medical Sciences , European Commission , Bureau Of Medical Administration , European Medicines Agency , Cancer Association , Drug Administration , Prnewswire Shanghai Henlius Biotech Inc , Journal Of The American Medical Association , Journal Of The National Cancer Center , National Health Commission Of The People , Cancer Association Sichuan Anti , Sasia Congress , National Medical Products Administration , Henlius Biotech , Executive Director , Chief Executive Officer , Chief Financial Officer , Cancer Hospital Chinese Academy , Medical Sciences ,

I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates

Significant progress made year-to-date on key clinical assets: ‐ Uliledlimab (CD73 antibody): Encouraging early results were presented at ASCO 2023 ‐. ....

United States , South Korea , Kalbe Genexine Biologics , Givastomig Claudin , Tyler Ehler , Raj Kannan , Gigi Feng , Biopharma Hangzhou Co Ltd , Board Of Directors The Company , European Society Of Medical Oncology , Corporate Development , Abbvie Inc , Key Clinical Program , Research Development Expenses , Exchange Commission , Exchange Rate Information , Human Immunology Biosciences Inc , Company Board Of Directors , Tracon Pharmaceuticals Inc , Topline Phase , Chief Executive Officer , Clinical Program , European Society , Medical Oncology , Myeloma Results Expected , Tracon Pharmaceuticals ,

Head-To-Head Comparison: I-Mab (NASDAQ:IMAB) versus Xilio Therapeutics (NASDAQ:XLO)

I-Mab (NASDAQ:IMAB – Get Rating) and Xilio Therapeutics (NASDAQ:XLO – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability. Analyst Recommendations This is a breakdown of recent recommendations and […] ....

United States , Kalbe Genexine Biologics , Xilio Therapeutics Inc , Sinopharm Group Co , Abbvie Ireland Unlimited Company , Get Rating , Xilio Therapeutics , Giveni Mab , Xilio Therapeutic , Sinopharm Group , Genexine Biologics , I Mab Daily ,